Yourgene inks agreement with US-based precision medicine company
(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.
Read moreWed, 25th Mar 2020 14:50
(Sharecast News) - Molecular diagnostics group Yourgene has inked a licence and supply agreement with an unnamed American precision medicine company.
Read moreTRADING UPDATES: Young's mulls asset sale; Ceres gets China investment
Read moreTRADING UPDATES: Forterra to beat outlook; Nostrum revenue falls
Read moreMyHealthChecked seals second Covid-19 test contract with Boots
Read moreTRADING UPDATES: STV looks to summer's football; In The Style sales up
Read moreIN BRIEF: Yourgene wins two tenders for national framework contract
Read more(Sharecast News) - Molecular diagnostics company Yourgene announced on Monday that Public Health England (PHE) has confirmed that it was successful with its tenders under PHE's National Microbiology Framework for 'Lot 2', for research and development goods and services, and 'Lot 3', for manufacturing, product development and commercialisation.
Read moreUPDATE: Yourgene wins further national framework contract award
Read moreYourgene wins national contract award for Covid-19 testing services
Read more(Sharecast News) - Molecular diagnostics provider Yourgene has been awarded a framework agreement under Public Health England's (PHE) National Microbiology Framework for diagnostic goods and services, it announced on Monday.
Read moreYourgene signs Covid test deal with MyHealthChecked to supply Boots
Read moreIN BRIEF: MyHealthChecked to sell Covid-19 tests in Boots stores
Read moreIN BRIEF: Yourgene Health Covid-19 test added to UK government list
Read moreTRADING UPDATES: Court approves Premier Oil and Chrysaor merger
Read moreEXECUTIVE CHANGES: Mitie, Pharos and Anpario promote finance chiefs
Read more